Outlook Therapeutics (OTLK) Inventory Average (2025 - 2026)

Outlook Therapeutics (OTLK) reported Inventory Average of $3.4 million for Q1 2026, up 1.32% year-over-year from $3.4 million in Q1 2025, and little changed quarter-over-quarter from $3.4 million in Q4 2025.

Outlook Therapeutics (OTLK) Inventory Average (2025 - 2026) Analysis & Trends

Outlook Therapeutics (OTLK) has 2 years of Inventory Average data on file, last reported at $3.4 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory Avg. (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 30.59 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 1.73 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Outlook Therapeutics 51.56 Mn 43.81 Mn -21,888.00 3.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.40 Mn
Dec 31, 2025 3.40 Mn
Sep 30, 2025 3.73 Mn
Jun 30, 2025 3.87 Mn
Mar 31, 2025 3.36 Mn